Merck and Co Inc (MRK)

[DewDiligence]

FDA approves MRK’s Recarbrio (a combination of three agents) for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia:

https://www.prnewswire.com/news-releases/fda-approves-antibiotic-to-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia-301071053.html

Recarbrio was previously FDA-approved for patients with complicated urinary tract infections and complicated intra-abdominal infections.